{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:48:52Z","timestamp":1780044532128,"version":"3.53.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.gore.2021.100851","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:08:46Z","timestamp":1629760126000},"page":"100851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Quaternary and beyond cytoreduction: An updated and expanded analysis"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-0457","authenticated-orcid":false,"given":"Beryl L.","family":"Manning-Geist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-4554","authenticated-orcid":false,"given":"Roisin E.","family":"O'Cearbhaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gore.2021.100851_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/canjclin.40.1.9","article-title":"Cancer Statistics, 1990","volume":"40","author":"Silverberg","year":"1990","journal-title":"Ca-Cancer J Clin."},{"issue":"1","key":"10.1016\/j.gore.2021.100851_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca-Cancer J Clin."},{"issue":"3","key":"10.1016\/j.gore.2021.100851_b0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","article-title":"Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer","volume":"126","author":"Cress","year":"2015","journal-title":"Obstet Gynecol."},{"issue":"20","key":"10.1016\/j.gore.2021.100851_b0020","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gore.2021.100851_b0025","doi-asserted-by":"crossref","unstructured":"Dubois, A. VI, Ferron, G., Reuss, A., Meier, W., Greggi, S. 2017. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20. J Clin Oncol. 35(15).","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"issue":"4","key":"10.1016\/j.gore.2021.100851_b0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.gore.2021.100851_b0035","first-page":"00421","article-title":"Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis","volume":"S0090\u20138258","author":"Manning-Geist","year":"2021","journal-title":"Gynecol Oncol."},{"issue":"9","key":"10.1016\/j.gore.2021.100851_b0040","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gore.2021.100851_b0045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2009.10.047","article-title":"Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer","volume":"116","author":"Shih","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2021.100851_b0050","doi-asserted-by":"crossref","unstructured":"Fotopoulou, C., Savvatis, K., Kosian, P., Braicu, I.E., Papanikolaou, G., Pietzner, K., et al. 2013. Quaternary Cytoreductive Surgery in Ovarian Cancer: Does Surgical Effort Still Matter? Obstet Gynecol Surv. 68(7), 519-20.","DOI":"10.1097\/01.ogx.0000432207.23416.c1"},{"issue":"6","key":"10.1016\/j.gore.2021.100851_b0055","first-page":"3519","article-title":"The Role of Quaternary Cytoreduction in Recurrent Epithelial Ovarian Cancer: A Single-center Experience","volume":"35","author":"Bacalbasa","year":"2015","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.gore.2021.100851_b0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","article-title":"Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study","volume":"7","author":"Omura","year":"1989","journal-title":"J Clin Oncol."},{"issue":"17","key":"10.1016\/j.gore.2021.100851_b0065","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1016\/j.gore.2021.100851_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol."},{"issue":"1","key":"10.1016\/j.gore.2021.100851_b0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"\u201cOptimal\u201d cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol."},{"issue":"2 Suppl 6","key":"10.1016\/j.gore.2021.100851_b0080","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2006.03.012","article-title":"Management of platinum-sensitive recurrent ovarian cancer","volume":"33","author":"Pfisterer","year":"2006","journal-title":"Semin Oncol."},{"issue":"4","key":"10.1016\/j.gore.2021.100851_b0085","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1245\/s10434-014-4141-4","article-title":"Development and assessment of Memorial Sloan Kettering Cancer Center's Surgical Secondary Events grading system","volume":"22","author":"Strong","year":"2015","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10.1016\/j.gore.2021.100851_b0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2018.06.015","article-title":"Moving beyond \u201ccomplete surgical resection\u201d and \u201coptimal\u201d: Is low-volume residual disease another option for primary debulking surgery?","volume":"150","author":"Manning-Geist","year":"2018","journal-title":"Gynecol Oncol."},{"issue":"4","key":"10.1016\/j.gore.2021.100851_b0095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1245\/s10434-012-2673-z","article-title":"Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation","volume":"20","author":"Fotopoulou","year":"2013","journal-title":"Ann Surg Oncol."},{"issue":"38","key":"10.1016\/j.gore.2021.100851_b0100","article-title":"Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III\/ENGTO-ov20","volume":"38","author":"Du Bois","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2021.100851_b0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2016.01.008","article-title":"Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center","volume":"140","author":"Mueller","year":"2016","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2021.100851_b0110","doi-asserted-by":"crossref","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","article-title":"Real-world evidence in the treatment of ovarian cancer","volume":"28","author":"Eisenhauer","year":"2017","journal-title":"Ann. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578921001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578921001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:56:24Z","timestamp":1762480584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578921001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":22,"alternative-id":["S2352578921001557"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2021.100851","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quaternary and beyond cytoreduction: An updated and expanded analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2021.100851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100851"}}